Autonomy Bio Inc. is an innovative biotechnology firm focused on advancing RNA-based therapeutics specifically designed to address challenging diseases, with a strong emphasis on oncology and infectious diseases. Leveraging proprietary technology, the company is committed to enhancing the precision and effectiveness of treatments to improve patient outcomes for complex conditions.
Company Values
Autonomy Bio stands out with its proprietary encrypted RNA technology that enables targeted therapeutic effects only in diseased cells, minimizing side effects on healthy cells.